(Date:11/19/2009)...Nov. 19 Dr. Mate Hidvegi, inventor...to a press release issued on November 17 by Biroph...aking false and self-serving statements about its ...idvegi stated from his office in Budapest, Hungary...emar does not apply to AveULTRA, www.aveultra.co...
(Date:11/19/2009)...ov. 19 Spherix Incorpora...y for diabetes therapy, and a provider of technica...lement, biotechnology and pharmaceutical companies...Meeting of Shareholders. ,, At the meeting, sha... elected the following members to the Board of Dir...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
(Date:11/19/2009)...nSound is honored by latest award for revolutionar...CA (PRWEB) November 16, 2009 -- Popular Science Ma... hearing aid from InSound Medical a winner of its ...th category. Chosen from th...eep in the hearing canal for up to four months whi...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3... Inc., a subsidiary of,Eisai Corporation of North ...ulti-centered Phase II study of its MORAb-009 mono...aluate MORAb-009, plus the chemotherapy drugs,peme...for patients with,mesothelioma. , The primary ...f MORAb-009,as combination therapy with the curren...
...ll/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: A...new Senior Secured Term Loan and Revolving Credit ...ranger, administrative agent and lender for both t...financing includes a delayed draw secured term loa...olving credit facility with a borrowing base deriv...
... the California Institute for Regenerative Medicin... Stemedica Cell Technologies, Inc. ("Stemedic...;D lab and corporate headquarters. , ...9 -- Leadership of the California Institute for Re... two part visit to Stemedica Cell Technologies, In...
Other Biology Technology:Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4CIRM Completes Briefing Visit to Stemedica Cell Technologies 2CIRM Completes Briefing Visit to Stemedica Cell Technologies 3Experion RNA StdSens Chips, 10 from Bio-Rad
MiniMACS Separation Unit from Miltenyi Biotec
Experion RNA HighSens Chips, 10 from Bio-Rad
...activated with carbonyl diimidazole chemistry that...e PS10 array contains the same binding chemistry a...hobic barrier coating. These arrays are 8 spot chi...ith one column of a standard 96-well microplate (9...
Biology Products: